Posts by: Iqra Mumal

Iqra Mumal

June 18, 2019June 18, 2019

Antineutrophil Cytoplasmic Antibodies Do Not Correlate with Disease Severity or Survival in North American IPF Patients

News

The presence of auto-antibodies (self-directed antibodies) known as antineutrophil cytoplasmic antibodies do not correlate with disease severity or survival in North American patients with idiopathic pulmonary fibrosis (IPF), according ... Read more

February 18, 2019February 27, 2019

Obstructive Sleep Apnea Plays Cognitive Impairment Role in IPF Patients, Study Suggests

News

Patients with idiopathic pulmonary fibrosis (IPF) have, on average, only slight cognitive impairment compared to healthy people. Also, IPF patients with severe obstructive sleep apnea have worse cognitive impairment. ... Read more

November 2, 2018November 27, 2018

Ofev of Less Benefit to Severe IPF Patients But Those Who Can Stay on Therapy Gain, Study Finds

News

Treatment with Ofev (nintedanib) offers less clinical benefit to patients with severe idiopathic pulmonary fibrosis (IPF) than to those with mild-to-moderate disease, but does improve outcomes if these patients are able ... Read more

October 29, 2018October 29, 2018

East River BioSolutions Awarded Grant to Develop Tools to Aid Lab Research on IPF

News

East River BioSolutions has received a $224,566 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to advance the development of laboratory ... Read more

October 24, 2018October 24, 2018

Mesenchymal Stem Cells from IPF Patients Show Impact of Disease, Study Says

News

Mesenchymal stem cells derived from the bone marrow of people with idiopathic pulmonary fibrosis (IPF) perform basic cell functions, like growing and dividing, more poorly than do these cells ... Read more

October 2, 2018October 8, 2018

Veracyte to Present New Results on Genomic Classifiers at CHEST 2018

News

Veracyte will present new results that showcase the ability of the Envisia Genomic Classifier to provide reliable data that helps physicians diagnose interstitial lung disease (ILD) — including idiopathic pulmonary ... Read more

September 17, 2018September 19, 2018

Cedars-Sinai Given $12M to Study IPF, Chronic Lung Allograft Dysfunction

News

The National Institutes of Health (NIH) has granted $12 million to researchers at Cedars-Sinai Medical Center to continue studying two lung diseases — idiopathic pulmonary fibrosis and chronic lung allograft dysfunction. Idiopathic pulmonary fibrosis (IPF) is characterized ... Read more

July 10, 2018July 18, 2018

Compound from Chinese Plant Seen to Protect Against Fibrosis in IPF Rat Model Study

News

Astragaloside IV — a compound isolated from a traditional Chinese medicinal plant — was found to reverse epithelial–mesenchymal transition, a process crucial to the progression of fibrosis, through its ... Read more

July 2, 2018July 6, 2018

Galectin Therapeutics Issued Patent for PF Therapy Candidate GR-MD-02

News

Galectin Therapeutics was issued a patent for its lead investigative therapy GR-MD-02 for the treatment of pulmonary fibrosis by the U.S. Patent and Trademark Office (USPTO), the company announced. GR-MD-02 is a carbohydrate-based ... Read more

June 20, 2018June 25, 2018

Serotonin Aggravates Pulmonary Fibrosis in Mice, Study Shows

News

Serotonin — a chemical produced by nerve cells — aggravated pulmonary fibrosis by promoting inflammation, oxidative stress (an imbalance between the production of reactive oxygen species and antioxidant defenses), ... Read more

Pin It on Pinterest